Stock Quote
Theragenics Corp (TGX) (NYSE Arca)
$1.28
23 Nov 2009
-2.29%
$1.31
$1.27
52,749
$1.32
$1.26
$1.89
$0.79
1.30
50,996
TGX
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Jacobs, M. Christine | Chairman of the Board, President, Chief Executive Officer | 1,129,560 |
| Tarallo, Francis | Chief Financial Officer, Treasurer | 556,134 |
| Routhier, Ronald | President - NeedleTech Products | -- |
Profile
Theragenics Corporation is a medical device company serving the surgical products and cancer treatment markets. The Company operates in two segments: brachytherapy seed business and the surgical products business. In the brachytherapy seed business, the Company produces, markets and sells TheraSeed,... Full Description
Company Address
Theragenics Corp
5203 Bristol Industrial Way
Buford GA 30518
P: +1770.2710233
F: +1770.8315294
5203 Bristol Industrial Way
Buford GA 30518
P: +1770.2710233
F: +1770.8315294
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| AngioDynamics, Inc. | $15.99 | +0.27 |
| Angiotech Pharmaceuticals, Inc. | $1.35 | -0.06 |
| Covidien PLC | $46.14 | +0.49 |
| TGX | Industry | |
|---|---|---|
| P/E(TTM) | -- | 3.57 |
| P/S(TTM) | 0.57 | 0.57 |
| ROI(TTM) | -46.61 | 1.86 |
| ROE(TTM) | -56.55 | 2.51 |
No consensus estimates data available.
| Total Revenue | $20.22M |
| Net Income | $1.27M |
| EPS | $0.04 |
